8-K current report · filed Oct 30, 2026

IRADIMED CORP (IRMD) 8-K Current Report: October 30, 2026

Item EX-99.1Item 2.02IRMD overview

Short answer

IRADIMED CORP (IRMD) filed an 8-K current report with the SEC on October 30, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). IRADIMED announced financial results for the quarter ended September 30, 2026.

IRADIMED CORP 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • IRADIMED announced financial results for the quarter ended September 30, 2026
  • Exhibit 99.1 contains the detailed earnings release and investor-relevant financial metrics
  • Results announcement dated October 30, 2026, marking the company’s latest quarterly performance update

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $24.2M, up 14% YoY, with net income $6.5M, up 17%, signaling strong operating momentum
  • 3870 pump launch gaining traction: over 70% of pump bookings were quad-stack configurations
  • Gross margin 76% versus 78% YoY, reflecting manufacturing ramp costs despite improving sequentially
  • Q4 revenue guidance $25.0M-$26.5M, while full-year revenue guidance narrowed to $91.6M-$93.1M
  • Quarterly dividend $0.20 per share, payable November 27, 2026 to November 13 record holders

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other IRADIMED CORP 8-K filings

Get the next IRMD 8-K as it lands

Follow IRMD for push alerts, or ask the research agent what this filing means.